Per the ATLANTIC study, using P2Y12 inhibitors in premedication in STEMI patients had no significant effect on thrombolysis in myocardial infarction or ST-segment elevation resolution before the interventional procedure.8 However, it may increase the risk of minor and major bleeding. This evidence concerns the gene P2RY12 and myocardial infarction.